A trial to Determine the Optimal early mobility Training after Stroke
AVERT DOSE: A trial to Determine the Optimal early mobility Training after Stroke
Lead PI: Prof Julie Bernhardt
No. of Patients Currently Recruited: 6 No. of Patients Required: 2700+
AVERT DOSE is a phase 3, Multi-Arm Multi-Stage Covariate-Adjusted Response-Adaptive Randomised Trial to Determine Optimal Early Mobility Training after Stroke. The Trial is Australian based, international 5 year academic study currently recruiting additional interested sites. Looking for interested stroke physiotherapist and nurse teams who have capacity and interest to participate. Current collaborations with UK, Ireland, Malaysia, Sinagapore, Taiwan and Brazil.